PCSA 8-K 2026-11-04

Processa Pharmaceuticals, Inc. (PCSA) 8-K dated 2026-11-04 — accession 0001140361-26-041901.

Processa Pharmaceuticals, Inc. (PCSA) is a biotechnology company listed on NASDAQ.

Processa Pharmaceuticals, Inc. filed a 8-K on 2026-11-04. Accession 0001140361-26-041901.

This 8-K covers: Director/officer change (Item 5.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PCSA revenue for 2022-12-31 was $0. Net income was -$27.4M. PCSA currently screens at market cap $5.9M.

Not investment advice. The PCSA SEC hub lists recent forms. The stock page is the research view.